期刊文献+

公民逝世后捐献肾脏的质量评估 被引量:6

Assessment of the kidney from donation after citizen's death
原文传递
导出
摘要 准确评估公民逝世后捐献肾脏的质量,可以避免供肾浪费,减少术后移植肾功能延迟恢复或移植肾原发性无功能的发生。目前临床通常对供肾进行肉眼大体观察、供者危险评分,有选择性地进行供肾活检,并结合肾脏低温机械灌注参数,以及供者血液、尿液和灌注液的分子诊断和生物标志物检测结果进行综合判定。尽管有多种评估技术,但仍无法精确评估供肾质量。当前,我国公民逝世后器官捐献案例正在快速增长中,亟待制订统一的标准来指导全国捐献器官的质量评估,推动其在临床上更规范、有效、安全地应用。 Accurate assessment of the kidney from donation after citizen's death,can avoid the waste of the donor kidney,reduce the incidence of postoperative delayed graft function or renal allograft primary nonfunction. Naturally,donor kidney will be examined through visual observation,donor risk score,selective renal biopsy,parameters of hypothermic machine pefusion,as well as comprehensive judgement on molecular diagnosis,and biomarker detection for blood,urine and perfusion solution.However,accurate quality assessment of donor kidney has get to be improved. At present,organ donation after citizen' s death in China is growing rapidly. It is very necessary to formulate unified quality assessment standards to guide the national organ donation,and promote the more standardized,effective and safe clinical application.
作者 杨顺良 谭建明 Yang Shunliang Tan Jianming(Urology Department, Fuzhou General Hospital, Organ Transplant Institute of PLA, Dongfang Hospital, Xiamen University, Fuzhou 350025, Chin)
出处 《中华移植杂志(电子版)》 CAS 2017年第2期75-79,共5页 Chinese Journal of Transplantation(Electronic Edition)
基金 福建省科技厅引导性项目(2015Y5007)
关键词 器官捐献 肾脏 质量 移植肾功能延迟恢复 评估 生物标志物 Organ donation Kidney Quality Delayed graft function Assessment Biomarker
  • 相关文献

参考文献3

二级参考文献27

  • 1Xu, Xiao,Ling, Qi,Wei, Qiang,Wu, Jian,Gao, Feng,He, Zeng-Lei,Zhou, Lin,Zheng, Shu-Sen.An effective model for predicting acute kidney injury after liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2010,9(3):259-263. 被引量:15
  • 2孙煦勇,赵月涛,文海涛,赖彦华,谭刘欣,董建辉,叶常青,武贵林,赵东海,李壮江.腹部多器官联合切取的临床研究(附72例报告)[J].中华肝胆外科杂志,2006,12(5):316-318. 被引量:16
  • 3Snoeijs MG, Boonstra LA, Buurman WA, et al. Histological assessment of pre-transplant kidney biopsies is reproducible and representative [ J ]. Histopathology, 2010,56 ( 2 ) : 198 - 202.
  • 4Chamorro C, Falc6n JA, Michelena JC. Controversial points in organ donor management[ J ]. Transplant Proc, 2009,41 (8) :3473-3475.
  • 5Bellingham JM, Santhanakrishnan C, Neidlinger N, et al. Donation after cardiac death: a 29-year experience [ J]. Surgery, 2011,150 (4) :692-702.
  • 6Dominguez-Gil B, Haase-Kromwijk B, Van Leiden H, et al. Current situation of donation after circulatory death in European countries [ J ]. Transpl Int, 2011,24 ( 7 ) :676-686.
  • 7Randhawa P. Role of donor kidney biopsies in renal transplantation [ J ]. Transolantation, 2001.71 ( 10 ) : 1361 - 1365.
  • 8Bellingham JM, Santhanakrishnan C, Neidlinger N, et al. Donation after cardiac death: a 29-year experience [J]. Surgery, 2011, 150 (4): 692-702.
  • 9Hoogland ER, Snoeijs MG, van Heurn LW. DCD kidney transplantation: results and measures to improve outcome [J]. Curr Opin Organ Transplant, 2010, 15 (2): 177-182.
  • 10Lewis J, Pehier J, Nelson H, et al. Development of the University of Wisconsin donation after cardiac death evaluation tool [ J ]. Prog Transplant, 2003, 13 (4) : 265 -273.

共引文献55

同被引文献46

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部